Nano-drug co-delivery system of natural active ingredients and chemotherapy drugs for cancer treatment: a review
B Li, H Shao, L Gao, H Li, H Sheng, L Zhu - Drug Delivery, 2022 - Taylor & Francis
Chemotherapy drugs have been used for a long time in the treatment of cancer, but serious
side effects are caused by the inability of the drug to be solely delivered to the tumor when …
side effects are caused by the inability of the drug to be solely delivered to the tumor when …
Nanoparticle-based drug delivery system: the magic bullet for the treatment of chronic pulmonary diseases
S Pramanik, S Mohanto, R Manne… - Molecular …, 2021 - ACS Publications
Chronic pulmonary diseases encompass different persistent and lethal diseases, including
chronic obstructive pulmonary disease (COPD), idiopathic pulmonary fibrosis (IPF), cystic …
chronic obstructive pulmonary disease (COPD), idiopathic pulmonary fibrosis (IPF), cystic …
Lipid polymer hybrid nanoparticles: a custom-tailored next-generation approach for cancer therapeutics
Lipid-based polymeric nanoparticles are the highly popular carrier systems for cancer drug
therapy. But presently, detailed investigations have revealed their flaws as drug delivery …
therapy. But presently, detailed investigations have revealed their flaws as drug delivery …
Triptolide: reflections on two decades of research and prospects for the future
Covering: 2000 to 2020 Triptolide is a bioactive diterpene triepoxide isolated from
Tripterygium wilfordii Hook F, a traditional Chinese medicinal plant whose extracts have …
Tripterygium wilfordii Hook F, a traditional Chinese medicinal plant whose extracts have …
Innovative nanomaterials for cancer diagnosis, imaging, and therapy: Drug delivery applications
M Pourmadadi, MM Eshaghi, S Ostovar… - Journal of Drug Delivery …, 2023 - Elsevier
The emergence of nanomedicine drugs as a result of the fast advancement of
nanotechnology offers enormous potential for improving cancer treatment strategies. The …
nanotechnology offers enormous potential for improving cancer treatment strategies. The …
[HTML][HTML] Triptolide: pharmacological spectrum, biosynthesis, chemical synthesis and derivatives
J Gao, Y Zhang, X Liu, X Wu, L Huang, W Gao - Theranostics, 2021 - ncbi.nlm.nih.gov
Triptolide, an abietane-type diterpenoid isolated from Tripterygium wilfordii Hook. F., has
significant pharmacological activity. Research results show that triptolide has obvious …
significant pharmacological activity. Research results show that triptolide has obvious …
[HTML][HTML] Lipid polymer hybrid nanocarriers: Insights into synthesis aspects, characterization, release mechanisms, surface functionalization and potential implications
Lipid polymer hybrid nanoparticles (LPHN) are novel systems which are potentially
emerging in the era of nano-medicine. They are core-shell nanostructures which comprise of …
emerging in the era of nano-medicine. They are core-shell nanostructures which comprise of …
Utilization of polymer-lipid hybrid nanoparticles for targeted anti-cancer therapy
Cancer represents one of the most dangerous diseases, with 1.8 million deaths worldwide.
Despite remarkable advances in conventional therapies, these treatments are not effective …
Despite remarkable advances in conventional therapies, these treatments are not effective …
Anti-lung cancer effect of paclitaxel solid lipid nanoparticles delivery system with curcumin as co-loading partner in vitro and in vivo
C Pi, W Zhao, M Zeng, J Yuan, H Shen, K Li, Z Su… - Drug Delivery, 2022 - Taylor & Francis
The main aim of this study was to improve the therapeutic potential of a paclitaxel (PTX) and
curcumin (CU) combination regimen using solid lipid nanoparticles (SLNs). PTX and CU …
curcumin (CU) combination regimen using solid lipid nanoparticles (SLNs). PTX and CU …
Herbal nanomedicines: Recent advancements, challenges, opportunities and regulatory overview
Abstract Background Herbal Nano Medicines (HNMs) are nano-sized medicine containing
herbal drugs as extracts, enriched fractions or biomarker constituents. HNMs have certain …
herbal drugs as extracts, enriched fractions or biomarker constituents. HNMs have certain …